| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,610 |
11,860 |
$565K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,653 |
4,506 |
$279K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,577 |
3,386 |
$255K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,345 |
5,067 |
$253K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,423 |
1,387 |
$125K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,464 |
3,334 |
$111K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
400 |
392 |
$38K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,461 |
1,404 |
$29K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,871 |
1,744 |
$28K |
| 71046 |
Radiologic examination, chest; 2 views |
1,252 |
1,207 |
$14K |
| 81025 |
|
1,222 |
1,172 |
$9K |
| 99000 |
|
663 |
648 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,134 |
1,076 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,539 |
1,478 |
$6K |
| 99201 |
|
196 |
189 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
90 |
90 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
148 |
143 |
$4K |
| 80053 |
Comprehensive metabolic panel |
436 |
425 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
445 |
429 |
$3K |
| 81001 |
|
1,037 |
991 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
12 |
$2K |
| 87081 |
|
484 |
461 |
$2K |
| 93000 |
|
157 |
149 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
461 |
451 |
$1K |
| 81003 |
|
491 |
481 |
$870.95 |
| 85027 |
|
156 |
152 |
$869.61 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
27 |
27 |
$823.33 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
27 |
27 |
$823.33 |
| 84484 |
|
66 |
62 |
$804.56 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
87 |
40 |
$788.10 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
56 |
53 |
$616.66 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$465.24 |
| 83690 |
|
61 |
58 |
$355.92 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
24 |
$284.92 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
147 |
138 |
$250.65 |
| 87210 |
|
28 |
28 |
$152.14 |
| 85379 |
|
12 |
12 |
$127.17 |
| 85007 |
|
12 |
12 |
$39.66 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$3.70 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
427 |
375 |
$0.00 |